Multitude Therapeutics (MTX) is a spinoff company created by Abmart to leverage its unparalleled target and antibody discovery capability for cancer immunotherapy. MTX focuses on developing novel antibody-drug conjugates (ADC), CAR-Ts and immuno-oncology antibodies for solid and hematological tumors. MTX’s therapeutic programs are based on novel cancer and immune cell surface targets discovered by monoclonal antibody arrays (Human Membrane Proteome MabArrayTM or HMP-MabArrayTM) powered by the exceptional antibody discovery capabilities built at Abmart.
| Website | https://www.multitudetherapeutics.info |
| Employees | 10 (10 on RocketReach) |
| Founded | 2018 |
| Address | 3698 Haven Ave, Redwood City, California 94063, US |
| Industry | Biotechnology Research, Drug Discovery, Pharmaceuticals |
| Keywords | Cancer Immunotherapy, Antibody Drug Conjugates, Car T Cell Therapy, Immuno Oncology, Oncology Therapeutics, Novel Therapeutics, Biotechnology, Pharmaceutical Research, Drug Development, Target Discovery, Antibody Discovery, Adc Technology, Immunotherapy Research, Cancer Research, Clinical Stage, Preclinical Development, Biopharmaceutical, Therapeutic Antibodies, Cancer Treatment |
| Competitors | Pfizer, AstraZeneca, Gilead Sciences, Illumina, Genentech, Regeneron, Alnylam Pharmaceuticals, CureVac, Novavax, Moderna Therapeutics +40 more (view full list) |
Looking for a particular Multitude Therapeutics employee's phone or email?
Multitude Therapeutics Questions
Shu-Hui Liu is the Chief Scientific Officer of Multitude Therapeutics.
10 people are employed at Multitude Therapeutics.
Multitude Therapeutics is based in Redwood City, California.
Top Multitude Therapeutics Employees
-
Shu-Hui Liu
Chief Scientific Officer at Multitude Therapeutics
Redwood City, CA, US22 -
Yaling Huang
Vice President at Multitude Therapeutics
Shanghai, China2 -
Shuang L.
Clinical Operations Director at Multitude Therapeutics
Melbourne, VIC, AU -
蒋岳云
BD Manager at Multitude Therapeutics
Xicheng District, Beijing, China
Related Companies
